Skip to main content

Table 1 Summary of clinical information for case and control groups enrolled in this study

From: Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2

Case/control group (or case #)

Average ± SD

Gestational age (week)

Fetal weight (g)

Placental weight (g)

Fetal weight/placental weight

Set I

 Control group I 1) (n = 39)

38.8 ± 1.3

3002 ± 407

506 ± 129

6.2 ± 1.9

 Case group I 1) (FGR and/or PIH, n = 140)

35.5 ± 4.4

1793 ± 596

277 ± 89

6.5 ± 1.7

 (statistical test p value)

(1.59 × 10−8)

(1.08 × 10−25)

(8.91 × 10−23)

(0.289)

 Case 1 (FGR)

30

724

115

6.3

 Case 2 (PIH)

30

1376

213

6.5

Set II

 Control group II 2) (n = 29)

39.1 ± 1.3

3059 ± 311

601 ± 100

5.2 ± 0.8

 Case group II 2) (FGR and/or PIH, n = 62)

35.7 ± 2.6

2017 ± 545

456 ± 127

4.5 ± 1.0

 (statistical test p value)

(3.81 × 10−10)

(1.00 × 10−25)

(3.42 × 10−7)

(0.0016)

 Case 3 (PIH)

33

1628

420

3.9

  1. 1)Chorionic plate tissues were collected for all cases and controls. Cord blood samples were collected for subset of cases and controls
  2. 2)Only chorionic villi were collected for all cases and controls